ClariVest Asset Management’s Medtronic MDT Stock Holding History

ClariVest Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$635	Hold	8	–	–	﹤0.01%	734
2024 Q2	$635	Buy	8 +5	+167%	+$410	﹤0.01%	734
2024 Q1	$261	Buy	+3	New	+$256	﹤0.01%	847
2023 Q4	–	Sell	-7	Closed	-$1K	–	927
2023 Q3	$1K	Buy	+7	New	+$586	﹤0.01%	666
2016 Q1	–	Sell	-3,911	Closed	-$301K	–	650
2015 Q4	$301K	Buy	3,911 +1,814	+87%	+$137K	0.01%	405
2015 Q3	$141K	Buy	2,097 +2,054	+4,777%	+$151K	﹤0.01%	452
2015 Q2	$3K	Hold	43	–	–	﹤0.01%	524
2015 Q1	$3K	Sell	43 -787	-95%	-$59.6K	﹤0.01%	522
2014 Q4	$60K	Hold	830	–	–	﹤0.01%	440
2014 Q3	$51K	Sell	830 -998	-55%	-$63.5K	﹤0.01%	469
2014 Q2	$117K	Buy	+1,828	New	+$111K	﹤0.01%	407

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ClariVest Asset Management's MDT Position: Q3 2024 in Review

ClariVest Asset Management held its Medtronic (MDT) position steady in Q3 2024 at 8 shares worth $635. The position accounts for ﹤0.01% of the portfolio, ranked #734.

ClariVest Asset Management first reported a position in MDT in Q2 2014 and has held it in 11 quarters since. The position peaked at $301K in Q4 2015. 2,069 funds tracked by Wall St. Rank hold MDT as of Q3 2024.

ClariVest Asset Management held 8 shares of Medtronic worth $635 as of Q3 2024.
ClariVest Asset Management left its Medtronic share count unchanged in Q3 2024.
Medtronic made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #734 holding.
ClariVest Asset Management first reported a position in Medtronic in Q2 2014 and has held it in 11 quarters since.
ClariVest Asset Management's Medtronic position peaked at $301K in Q4 2015.
2,069 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.